Rationale and Design of the PROSPECTIVE Trial: Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Prior Coronary Heart Disease

Background: Reduction of serum LDL-cholesterol by statins was shown to improve clinical outcomes in patients with coronary heart disease (CHD). Although intensive statin therapy significantly reduced cardiovascular risks, atherosclerotic cardiovascular events have not been completely prevented. Ther...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Atheroscler Thromb
Main Authors: Yamashita, Shizuya, Masuda, Daisaku, Ohama, Tohru, Arai, Hidenori, Bujo, Hideaki, Kagimura, Tatsuo, Kita, Toru, Matsuzaki, Masunori, Saito, Yasushi, Fukushima, Masanori, Matsuzawa, Yuji
格式: Artigo
語言:Inglês
出版: Japan Atherosclerosis Society 2016
主題:
Study Profile
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7399286/
https://ncbi.nlm.nih.gov/pubmed/26803913
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.32813
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍